Otsuka (France)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 10 papers

  • Abstract

Analyse des discussions des patients atteints de lupus à partir des forums publics de l’internet en France

  • Jun 01, 2022
  • La Revue de Médecine Interne
  • M Riviere +2
  • Open Access
  • Abstract
  • Citations2

PMH13 - Schizophrenia: Study of Epidemiological and Economic Regional Disparities

  • Sep 01, 2018
  • Value in Health
  • Pg Larroumets
  • Research Article
  • Citations24

Patients' perspectives on residual symptoms in bipolar disorder: a focus group study.

  • Jul 01, 2014
  • Journal of Nervous & Mental Disease
  • Ludovic Samalin +10
  • Abstract

PW01-36 - The long-term safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar I patients partially non-responsive to mood stabilisers

  • Jan 01, 2010
  • European Psychiatry
  • E Vieta +7
  • Abstract

P01-58 - Adjunctive aripiprazole in patients with major depressive disorder: pooled data on functioning from three clinical trials

  • Jan 01, 2010
  • European Psychiatry
  • J.-Y Loze +9
  • Abstract

P01-39 - Adjunctive aripiprazole in patients with major depressive disorder: efficacy data from three short-term studies

  • Jan 01, 2010
  • European Psychiatry
  • R Gismondi +4
  • Abstract

P01-38 - Efficacy of adjunctive aripiprazole in patients with major depressive disorder: pooled analysis of subgroup data from three clinical trials

  • Jan 01, 2010
  • European Psychiatry
  • R Gismondi +4
  • Open Access
  • Abstract

P01-57 - Analysis of pooled safety data from three randomized, double-blind, placebo-controlled studies of adjunctive aripiprazole in major depressive disorder

  • Jan 01, 2010
  • European Psychiatry
  • J.-Y Loze +4
  • Abstract
  • Citations1

P03-182 A 16-week, multicentre, randomized, open-label study assessing effects of aripiprazole versus other atypicals for schizophrenia patients with metabolic syndrome

  • Jan 01, 2009
  • European Psychiatry
  • H Day-Poulsen +5
  • Research Article
  • Citations19

Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: Results from the STAR study

  • Apr 18, 2008
  • European Psychiatry
  • David Taylor +5
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.